· *Novavax shares leaped as much as 13.3% on Friday after finalizing a deal with the UK to supply 60 million doses of its potential coronavirus vaccine.*
· *The biotech company didn't reveal how much the UK paid for the doses.*
· *The UK government will collaborate with Novavax on phase 3 trials of its NVX-CoV2373 vaccine,...
Novavax soars 13% after inking deal with UK for 60 million doses of coronavirus vaccine
Business Insider
0 shares
1 views
You might like
Related news coverage
Canada strikes more deals for COVID-19 vaccine, but may have to wait in line behind other nations
National Post
Capping a flurry of procurement announcements Monday, the federal government made a bold claim: Canada would be at the “front of..
-
U.S. drug company Novavax signs deal to supply 76M doses of possible COVID-19 vaccine to Canada
CBC.ca
-
U.S. drug company Novavax signs deal to supply 76 million doses of possible COVID-19 vaccine to Canada
CBC.ca
-
Feds sign deal with Novavax to secure up to 76M doses of vaccine candidate
CTV News
-
Bill Gates-backed CureVac jumps 18% on report it's in advanced talks with the EU for 225 million doses of its potential COVID-19 vaccine (CVAC)
Business Insider
Advertisement
More coverage
North Macedonia Hopes Stimulus Medicine Will ‘Immunize’ Economy Against COVID-19 – Analysis
Eurasia Review
As scientists race to find a vaccine against coronavirus, governments in the Balkans and elsewhere trust massive stimulus packages..
Australia signs deal for Oxford coronavirus vaccine
Belfast Telegraph